2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
ASCO® 2024 Insights: "PIVOTAL Study - Neoadjuvant Daromun vs. Immediate Surgery in Fully Resectable Melanoma"
By
ecancer
FEATURING
Axel Hauschild
By
ecancer
FEATURING
Axel Hauschild
Login to view comments.
Click here to Login